Figure 1 summarizes evidence that abnormal T-cell signaling leads to overproduction of IL-17 in SLE, which in turn activates immune and other cells, leading to autoantibody production and proinflammatory cytokine production, resulting in organ damage. This evidence concerns the gene IL17A and systemic lupus erythematosus.